Basic Lab Interpretation with Case Studies
This presentation will discuss common laboratory studies utilizing a case-based method. Then review decision-making strategies including the selection of the most appropriate tests for the clinical presentation, based on the current evidence. Lastly, explore the interpretation of the potential findings and develop the best treatment plans as well as any necessary follow-up that may be needed based on the findings.
Credits: 1.00 contact hours; 0.25 are pharmacology
Release Date: March 1, 2021
End Date: March 1, 2022
As a result of this activity, the learner will be able to:
- Identify strategies for selecting and interpreting basic lab studies
- Analyze basic lab studies to determine patient risk and identify pathology
- Develop plans of care based on the interpretation of basic lab studies
Susan Feeney, DNP, FNP-BC
Assistant Professor; Director of NP Tracks, UMMS Graduate School of Nursing
FNP; Worcester State Student Health Center
Dr. Susan Feeney is an Assistant Professor at UMass Medical School Graduate School of Nursing and is the Director of Nurse Practitioner Tracks (AG-ACNP, AG-PCNP, FNP, PMHNP). She provided comprehensive primary care for over 22 years, practicing 10 of those years in an independent NP-owned practice, and she currently practices in College Health. Dr. Feeney has been an educator for over 20 years, dedicated to teaching, mentoring and supporting NP students. She is a Senior Faculty in Fitzgerald Health Education Associates teaching certification review courses and contributes to the PriMed’s Frankly Speaking Podcasts, focusing on evidenced-based primary care practice. Dr. Feeney speaks both regionally and nationally on many topics pertaining to primary care, including vaping, women’s health, antibiotic stewardship and lab interpretation. She has contributed to primary care and case study textbooks and authored several articles. Dr. Feeney served as Vice President (2014-2016) and President of NHNPA (2016-2018) and is an active member of MCNP.
Obtain Your Credits
To earn credits for this activity, you must complete all course components in the following order: 1) complete a three-question pre-test; 2) watch the course presentation video; 3) complete the course evaluation; 4) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile dashboard transcript for future access.
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 0.25 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
Contributing faculty, Susan Feeney, DNP, FNP-BC, have disclosed no relevant financial relationships.
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
There is no commercial support for this activity.
|Access Date||Quiz Result||Score||Actions|